These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11129249)

  • 1. Impaired erythrocyte transmembrane potential in diabetes mellitus and its possible improvement by resorcylidene aminoguanidine.
    Waczulíková I; Sikurová L; Bryszewska M; R kawiecka K; Cársky J; Ulicná O
    Bioelectrochemistry; 2000 Dec; 52(2):251-6. PubMed ID: 11129249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluidity gradient of erythrocyte membranes in diabetics: the effect of resorcylidene aminoguanidine.
    Waczulíková I; Sikurová L; Cársky J
    Bioelectrochemistry; 2002 Jan; 55(1-2):53-5. PubMed ID: 11786339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resorcylidene aminoguanidine improves the pathologically reduced fluidity of erythrocyte membranes in diabetes mellitus.
    Sikurová L; Dérerová J; Kvasnicka P; Waczulíková I; Cársky J; Ulicná O
    Pharmazie; 2000 Sep; 55(9):700-1. PubMed ID: 11031780
    [No Abstract]   [Full Text] [Related]  

  • 5. Human red blood cell membrane potential and fluidity in glucose solutions.
    Zavodnik IB; Piasecka A; Szosland K; Bryszewska M
    Scand J Clin Lab Invest; 1997 Feb; 57(1):59-63. PubMed ID: 9127458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of lipid peroxidation in erythrocytes by aminoguanidine, resorcylidine aminoguanidine and their oxygen and sulfur analogs in diabetic rats].
    Hrnciarová M; Cársky J; Jakuś V; Zlatos L; Kucharská J; Gvozdjáková A
    Bratisl Lek Listy; 1998 Jul; 99(7):364-7. PubMed ID: 9748726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of selected membrane active substances on erythrocyte deformability.
    Beder I; Kittova M; Mataseje A; Carsky J; Orszaghova Z; Babinska K
    Bratisl Lek Listy; 2003; 104(2):69-72. PubMed ID: 12839215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodelling of the sarcolemma in diabetic rat hearts: the role of membrane fluidity.
    Ziegelhöffer-Mihalovicová B; Waczulíková I; Sikurová L; Styk J; Cársky J; Ziegelhöffer A
    Mol Cell Biochem; 2003 Jul; 249(1-2):175-82. PubMed ID: 12956413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity.
    Watala C; Dobaczewski M; Kazmierczak P; Gebicki J; Nocun M; Zitnanova I; Ulicna O; Durackova Z; Waczulíková I; Carsky J; Chlopicki S
    Vascul Pharmacol; 2009 Oct; 51(4):275-83. PubMed ID: 19635586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of extracellular Ca2+, K+ and OH- on erythrocyte membrane potential as monitored by the fluorescent probe 3,3'-dipropylthiodicarbocyanine.
    Pape L
    Biochim Biophys Acta; 1982 Apr; 686(2):225-32. PubMed ID: 7082665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resorcylidene aminoguanidine (RAG) improves cardiac mitochondrial bioenergetics impaired by hyperglycaemia in a model of experimental diabetes.
    Labieniec-Watala M; Siewiera K; Jozwiak Z
    Int J Mol Sci; 2011; 12(11):8013-26. PubMed ID: 22174647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity.
    Jakus V; Hrnciarová M; Cársky J; Krahulec B; Rietbrock N
    Life Sci; 1999; 65(18-19):1991-3. PubMed ID: 10576452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of resorcylidene aminoguanidine (RAG) on selected parameters of isolated rat liver mitochondria.
    Labieniec M; Przygodzki T; Cársky J; Malinska D; Rysz J; Watala C
    Chem Biol Interact; 2009 May; 179(2-3):280-7. PubMed ID: 19061873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ascorbate-driven reduction of extracellular ascorbate free radical by the erythrocyte is an electrogenic process.
    VanDuijn MM; Van der Zee J; Van den Broek PJ
    FEBS Lett; 2001 Feb; 491(1-2):67-70. PubMed ID: 11226421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal properties and fluidity of human erythrocyte membranes in diabetes mellitus.
    Przybylska M; Bryszewska M; Chapman IV
    Int J Radiat Biol; 1993 Mar; 63(3):419-24. PubMed ID: 8095294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type 1 (insulin-dependent) diabetic patients.
    Juhan-Vague I; Rahmani-Jourdheuil D; Mishal Z; Roul C; Mourayre Y; Aillaud MF; Vague P
    Diabetologia; 1986 Jul; 29(7):417-20. PubMed ID: 3527841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus.
    Wali RK; Jaffe S; Kumar D; Kalra VK
    Diabetes; 1988 Jan; 37(1):104-11. PubMed ID: 3335275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluidising effect of resorcylidene aminoguanidine on sarcolemmal membranes in streptozotocin-diabetic rats: blunted adaptation of diabetic myocardium to Ca2+ overload.
    Waczulíková I; Ziegelhöffer A; Országhová Z; Cársky J
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 2):727-39. PubMed ID: 12510859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DiO-C3-(5) and DiS-C3-(5): Interactions with RBC, ghosts and phospholipid vesicles.
    Guillet EG; Kimmich GA
    J Membr Biol; 1981 Mar; 59(1):1-11. PubMed ID: 7241571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature sensitivity of the erythrocyte membrane potential as determined by cyanine dye fluorescence.
    Mikkelsen RB; Wallach DF
    Cell Biol Int Rep; 1977 Jan; 1(1):51-5. PubMed ID: 610867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.